About
ADvantage Therapeutics is a clinical-stage biopharmaceutical company headquartered in the Wynwood neighborhood of Miami, focused on developing therapies for neurodegenerative diseases, with a primary emphasis on Alzheimer’s disease. Its lead candidate, AD04™, is an injectable immunomodulatory therapy preparing to enter confirmatory Phase 2b clinical trials in Europe to assess its safety and efficacy in early Alzheimer’s patients. Unlike treatments that target protein aggregation after disease onset, AD04™ is designed to stimulate and regulate the immune system to reduce Alzheimer’s pathology earlier in the disease process. The company is also actively pursuing additional therapeutic strategies that aim to address neurodegeneration and support healthier longevity.
MiamiHealth Care